Nephrology
Program Profile
VA-Based Peritoneal Dialysis Program Feasibility Considerations and Process Outline
Compared with hemodialysis (HD), peritoneal dialysis (PD) offers comparable survival and superior patient-centered and...
News
SGLT2 inhibitors: Real-world data show benefits outweigh risks
“The importance of our paper is that it quantifies the absolute rate of events among routine care patients and may be used to inform shared...
News
Experts share early details prescribing avacopan for ANCA-associated vasculitis
Rheumatologists said more data are needed to determine optimal glucocorticoid tapering and treatment duration of avacopan for patients with ANCA-...
News
Can SGLT2 inhibitors limit acute kidney injury in type 2 diabetes?
Contrary to the initial concerns that SGLT2 inhibitors might increase the risk of acute kidney injury, new data indicate that this complication is...
News
Experts share real-world experience prescribing voclosporin, belimumab for lupus nephritis
While some rheumatologists expressed a treatment preference, patients with lupus nephritis tend to do well on both medications; however, cost and...
News
Dapagliflozin reduces hospitalizations in patients with CKD
A new analysis adds to a growing body of evidence supporting a range of positive benefits from dapagliflozin.
Conference Coverage
Dialysis not always best option in advanced kidney disease
“We’ve recognized for a long time that there are many patients for whom dialysis provides neither a survival advantage nor a quality of life...
News
Promising new antibiotic emerges for treating UTIs
It would be the first new treatment in 20 years for UTIs, which affect more than half of women at least sometime in their lives.
Conference Coverage
Study sheds new light on RAS inhibitors’ role for advanced CKD
“The results of this trial will inform future clinical practice worldwide and guideline recommendations.”
News
Islet transplants in type 1 diabetes durable up to 8 years
Long-term insulin independence and safety is seen with islet-cell transplant in patients with severe hypoglycemia at baseline.